FILTER
FILTERED INTERVIEW RESULTS
William Tan
GENERAL MANAGER, EMERSON AUTOMATION SOLUTIONS
Emerson explains its role in the digital transformation of the process industries in Singapore.
Kenneth Lim
ASSISTANT CHIEF EXECUTIVE (INDUSTRY), MARITIME AND PORT AUTHORITY OF SINGAPORE
The Maritime and Port Authority in Singapore explains its initiatives to retain its global leadership.
Wayne Yap
EXECUTIVE DIRECTOR, ASPRI (ASSOCIATION OF PROCESS INDUSTRY)
ASPRI is a Singapore trade association that represents the interests of more than 550 corporate members in the Process Industry.
Kevin McGuigan
VP AND MANAGING DIRECTOR, 3M (SOUTHEAST ASIA)
3M explains its Singapore operations and the path to sustainability.
Terence Koh
EXECUTIVE DIRECTOR SCIC (SINGAPORE CHEMICAL INDUSTRY COUNCIL)
The Singapore Chemical Industry Council explains how it is working to eliminate plastic waste.
Luis Eduardo González
THE MEXICAN UNION OF AGROCHEMICALS MANUFACTURERS AND FORMULATORS (UMFFAAC)
The Mexican Union of Agrochemicals Manufacturers and Formulators (UMFFAAC) describes the main themes impacting its members.
Cristian García
EXECUTIVE DIRECTOR, ASSOCIATION OF CROP PROTECTION, SCIENCE AND TECHNOLOGY (PROCCYT)
Cristian García of PROCCYT explains the dynamics influencing Mexico’s crop protecting sector.
Carlos Jurado
LATIN AMERICAN NORTH BUSINESS DIRECTOR, FMC
FMC discusses the rise of sustainable products which have minimal residues on crops.
Marco Salcedo
DIRECTOR GENERAL – MEXICO, AMVAC
Marco Salcedo explains how new technologies and M&A are helping AMVAC grow in Mexico.
Manuel Gurrola
PRESIDENT, GRUPO LUCAVA
Manuel Gurrola details Grupo Lucava’s evolution in the agrochemical’s industry.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
